During the past decade, Personalized Orthopedic Research Institute conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Personalized Orthopedic Research Institute" are "Osteoarthritis, Knee" (2 trials), "Clinical Condition Included in the Approved Indications For Use for the Conformis Hip System" (1 trials), "Knee Osteoarthritis" (1 trials) and "Osteoarthritis" (1 trials). Many other conditions were trialed in "Personalized Orthopedic Research Institute" in a lesser frequency.

Most popular intervention types in "Personalized Orthopedic Research Institute" are "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "ConforMIS iUni, iDuo, or iTotal (CR)" (1 trials), "Conformis Hip System" (1 trials), "Conformis iTotal Identity Knee Replacement System" (1 trials) and "iTotal KRS" (1 trials). Other intervention names were less common.

The vast majority of trials in "Personalized Orthopedic Research Institute" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Personalized Orthopedic Research Institute". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Personalized Orthopedic Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Personalized Orthopedic Research Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".